Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Harprit Singh: Future – Ready Hospitals Will Have Apheresis Hubs, Not Just Dialysis Units
Apr 4, 2026, 10:36

Harprit Singh: Future – Ready Hospitals Will Have Apheresis Hubs, Not Just Dialysis Units

Harprit Singh, Associate Director at Transfusion Technologies, Therapies, Solutions and Consultant in Transfusion Medicine at Alchemist Hospital, shared a post on LinkedIn:

“Future – Ready Hospitals Will Have Apheresis Hubs – Not Just Dialysis Units

Most hospitals don’t have an apheresis problem.

They have a utilization problem.

In multiple institutions I’ve worked with, the pattern is consistent:

  • Apheresis machines exist.
  • Clinical expertise exists.
  • But activation pathways don’t.

The result?

  • Delayed therapeutic plasma exchange (TPE)
  • Underutilized apheresis services
  • Missed integration with solid organ and bone marrow transplant (BMT) and oncology
  • Higher ICU burden and avoidable costs

This is where strategy changes everything.

Hospitals that build Clinical Apheresis Hubs – not fragmented services – unlock the following:

  • Faster intervention in critical care
  • Seamless transplant and cellular therapy workflows
  • Reduced ICU dependency

High-value, predictable clinical revenue

Because an Apheresis Hub is not equipment.

It is a clinical plus operational plus financial system.

Protocols define speed

Ownership defines utilisation.

The question is no longer:

‘Do we have apheresis?’

It is:

‘Is it integrated into how we deliver care?’

For COs and administrators, this is where transfusion medicine becomes strategy – not support.

A practical starting point:

Map 3 things

Who triggers apheresis?

How fast can it be activated?

How often is iused?

An open question:

What is the single biggest barrier to apheresis utilisation in your institution today?”

 

Stay updated with Hemostasis Today.